These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 9488035)

  • 1. Identification of a tumor-specific methylation site in the Wilms tumor suppressor gene.
    Kleymenova EV; Yuan X; LaBate ME; Walker CL
    Oncogene; 1998 Feb; 16(6):713-20. PubMed ID: 9488035
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Wilms' tumor suppressor gene (WT1) is expressed in primary breast tumors despite tumor-specific promoter methylation.
    Loeb DM; Evron E; Patel CB; Sharma PM; Niranjan B; Buluwela L; Weitzman SA; Korz D; Sukumar S
    Cancer Res; 2001 Feb; 61(3):921-5. PubMed ID: 11221883
    [TBL] [Abstract][Full Text] [Related]  

  • 3. WT1 mutation in malignant mesothelioma and WT1 immunoreactivity in relation to p53 and growth factor receptor expression, cell-type transition, and prognosis.
    Kumar-Singh S; Segers K; Rodeck U; Backhovens H; Bogers J; Weyler J; Van Broeckhoven C; Van Marck E
    J Pathol; 1997 Jan; 181(1):67-74. PubMed ID: 9072005
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Transcriptional regulation of the androgen signaling pathway by the Wilms' tumor suppressor gene WT1.
    Zaia A; Fraizer GC; Piantanelli L; Saunders GF
    Anticancer Res; 2001; 21(1A):1-10. PubMed ID: 11299720
    [TBL] [Abstract][Full Text] [Related]  

  • 5. DNA methylation in the androgen receptor gene promoter region in rat prostate cancers.
    Takahashi S; Inaguma S; Sakakibara M; Cho YM; Suzuki S; Ikeda Y; Cui L; Shirai T
    Prostate; 2002 Jun; 52(1):82-8. PubMed ID: 11992622
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Activation of the wt1 Wilms' tumor suppressor gene by NF-kappaB.
    Dehbi M; Hiscott J; Pelletier J
    Oncogene; 1998 Apr; 16(16):2033-9. PubMed ID: 9572484
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Wilms tumour gene WT1 is expressed in murine mesoderm-derived tissues and mutated in a human mesothelioma.
    Park S; Schalling M; Bernard A; Maheswaran S; Shipley GC; Roberts D; Fletcher J; Shipman R; Rheinwald J; Demetri G
    Nat Genet; 1993 Aug; 4(4):415-20. PubMed ID: 8401592
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Wilms' tumor suppressor gene expression in rat and human mesothelioma.
    Walker C; Rutten F; Yuan X; Pass H; Mew DM; Everitt J
    Cancer Res; 1994 Jun; 54(12):3101-6. PubMed ID: 8205524
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Molecular heterogeneity and function of EWS-WT1 fusion transcripts in desmoplastic small round cell tumors.
    Liu J; Nau MM; Yeh JC; Allegra CJ; Chu E; Wright JJ
    Clin Cancer Res; 2000 Sep; 6(9):3522-9. PubMed ID: 10999739
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Isoschizomers and amplified fragment length polymorphism for the detection of specific cytosine methylation changes.
    Ruiz-García L; Cabezas JA; de María N; Cervera MT
    Methods Mol Biol; 2010; 631():63-74. PubMed ID: 20204869
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification of differentially methylated sites within unmethylated DNA domains in normal and cancer cells.
    Tryndyak V; Kovalchuk O; Pogribny IP
    Anal Biochem; 2006 Sep; 356(2):202-7. PubMed ID: 16824473
    [TBL] [Abstract][Full Text] [Related]  

  • 12. WT1 and WT1-AS genes are inactivated by promoter methylation in ovarian clear cell adenocarcinoma.
    Kaneuchi M; Sasaki M; Tanaka Y; Shiina H; Yamada H; Yamamoto R; Sakuragi N; Enokida H; Verma M; Dahiya R
    Cancer; 2005 Nov; 104(9):1924-30. PubMed ID: 16134181
    [TBL] [Abstract][Full Text] [Related]  

  • 13. EGR-1 enhances tumor growth and modulates the effect of the Wilms' tumor 1 gene products on tumorigenicity.
    Scharnhorst V; Menke AL; Attema J; Haneveld JK; Riteco N; van Steenbrugge GJ; van der Eb AJ; Jochemsen AG
    Oncogene; 2000 Feb; 19(6):791-800. PubMed ID: 10698497
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Wilms' tumor gene WT1 can regulate genes involved in sex determination and differentiation: SRY, Müllerian-inhibiting substance, and the androgen receptor.
    Shimamura R; Fraizer GC; Trapman J; Lau YfC ; Saunders GF
    Clin Cancer Res; 1997 Dec; 3(12 Pt 2):2571-80. PubMed ID: 9815658
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Analysis of possible WT1 RNA processing in primary Wilms tumors.
    Gunning KB; Cohn SL; Tomlinson GE; Strong LC; Huff V
    Oncogene; 1996 Sep; 13(6):1179-85. PubMed ID: 8808692
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The role of Wilms' tumor genes.
    Hirose M
    J Med Invest; 1999 Aug; 46(3-4):130-40. PubMed ID: 10687307
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Neurofibromatosis type 2 (NF2) gene is somatically mutated in mesothelioma but not in lung cancer.
    Sekido Y; Pass HI; Bader S; Mew DJ; Christman MF; Gazdar AF; Minna JD
    Cancer Res; 1995 Mar; 55(6):1227-31. PubMed ID: 7882313
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Characterization of the rat neurofibromatosis 2 gene and its involvement in asbestos-induced mesothelioma.
    Kleymenova EV; Bianchi AA; Kley N; Pylev LN; Walker CL
    Mol Carcinog; 1997 Jan; 18(1):54-60. PubMed ID: 9022813
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Wilms tumor and the WT1 gene.
    Lee SB; Haber DA
    Exp Cell Res; 2001 Mar; 264(1):74-99. PubMed ID: 11237525
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Wilms' tumor 1 susceptibility (WT1) gene products are selectively expressed in malignant mesothelioma.
    Amin KM; Litzky LA; Smythe WR; Mooney AM; Morris JM; Mews DJ; Pass HI; Kari C; Rodeck U; Rauscher FJ
    Am J Pathol; 1995 Feb; 146(2):344-56. PubMed ID: 7856747
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.